TOMI Environmental Solutions, Inc. Announces Cost Reduction Efforts to Sustain Long Term Growth and Achieve Profitability
June 06, 2024 12:45 ET
|
TOMI Environmental Solutions, Inc.
Company restructures executive compensation and reduces external consulting fees Expects to reduce cash used in operations by 30% (Approximately $500,000) by end of 2024 Company to continue to...
CG Oncology Announces Nature Medicine Publication of Final Results from CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive NMIBC
June 06, 2024 12:14 ET
|
CG Oncology Inc.
CG Oncology Announces Nature Medicine Publication of Final Results from CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab
QXO Announces Leadership Team and Board of Directors
June 06, 2024 11:49 ET
|
QXO, Inc.
GREENWICH, Conn., June 06, 2024 (GLOBE NEWSWIRE) -- Brad Jacobs, chairman and chief executive officer of QXO, Inc. (Nasdaq: QXO), today announced the appointment of eight executives and six members...
QXO Completes $1 Billion Equity Investment
June 06, 2024 11:46 ET
|
QXO, Inc.
GREENWICH, Conn., June 06, 2024 (GLOBE NEWSWIRE) -- QXO, Inc. (“QXO” or the “Company”), formerly known as SilverSun Technologies, Inc. (“SilverSun”), today completed the previously announced equity...
Treatment with Arbutus’ Imdusiran and VTP-300 Achieves Statistical Significance in Lowering HBsAg Levels
June 06, 2024 11:15 ET
|
Arbutus Biopharma Corporation
Data highlighted in oral presentation at the European Association for the Study of the Liver (EASL) Congress WARMISTER, Pa., June 06, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation...
Barinthus Bio's VTP-300 Trials Demonstrate Ability to Achieve Undetectable HBsAg levels and Statistical Significance in Lowering HBsAg Levels in People with Chronic Hepatitis B
June 06, 2024 11:15 ET
|
Barinthus Biotherapeutics
Barinthus Bio presents updated data from two clinical trials in people with chronic hepatitis B at EASL Congress 2024.
Tonix Pharmaceuticals Announces 1-for-32 Reverse Stock Split
June 06, 2024 11:00 ET
|
Tonix Pharmaceuticals Holding Corp.
CHATHAM, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), fully-integrated biopharmaceutical company with marketed products and a...
Freshworks Completes Acquisition of Device42
June 06, 2024 10:55 ET
|
Freshworks Inc
Enhances IT Asset Management Capabilities Designed to Provide Customers with a Single, Integrated Platform New Capabilities Help Customers Reduce Risk, Solve Incidents Faster SAN MATEO, Calif.,...
Rapid7 Wins Best SIEM Solution at SC Awards Europe 2024
June 06, 2024 10:14 ET
|
Rapid7
BOSTON, June 06, 2024 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a leader in extended risk and threat detection, today announced that InsightIDR was recognized as Best SIEM Solution at the SC...
FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024
June 06, 2024 09:31 ET
|
Fibrobiologics, Inc.
HOUSTON, June 06, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the...